Your browser doesn't support javascript.
loading
PAX5 P80R mutation identifies a novel subtype of B-cell precursor acute lymphoblastic leukemia with favorable outcome.
Passet, Marie; Boissel, Nicolas; Sigaux, François; Saillard, Colombe; Bargetzi, Mario; Ba, Ibrahima; Thomas, Xavier; Graux, Carlos; Chalandon, Yves; Leguay, Thibaut; Lengliné, Etienne; Konopacki, Johanna; Quentin, Samuel; Delabesse, Eric; Lafage-Pochitaloff, Marina; Pastoret, Cédric; Grardel, Nathalie; Asnafi, Vahid; Lhéritier, Véronique; Soulier, Jean; Dombret, Hervé; Clappier, Emmanuelle.
Afiliação
  • Passet M; Hematology Laboratory, Saint-Louis Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France.
  • Boissel N; University Paris Diderot, Paris, France.
  • Sigaux F; INSERM U944/CNRS UMR7212, Institut Universitaire d'Hématologie, Paris, France.
  • Saillard C; University Paris Diderot, Paris, France.
  • Bargetzi M; Clinical Hematology Department, Saint-Louis Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France.
  • Ba I; EA-3518, Institut Universitaire d'Hématologie, Paris, France.
  • Thomas X; University Paris Diderot, Paris, France.
  • Graux C; Commissariat à l'Energie Atomique et aux Énergies Renouvelables, Saclay, France.
  • Chalandon Y; Service d'Hématologie 2, Institut Paoli-Calmettes, Marseille, France.
  • Leguay T; Onkologie/Hämatologie, Kantonsspital Aarau AG, Aarau, Switzerland.
  • Lengliné E; Swiss Group for Clinical Cancer Research, Bern, Switzerland.
  • Konopacki J; Hematology Laboratory, Saint-Louis Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France.
  • Quentin S; INSERM U944/CNRS UMR7212, Institut Universitaire d'Hématologie, Paris, France.
  • Delabesse E; Hématologie Marcel Bérard, Centre Hospitalier Lyon Sud, Pierre Bénite, France.
  • Lafage-Pochitaloff M; Service d'Hématologie, CHU UCL Mont Godine, Yvoir, Belgium.
  • Pastoret C; Swiss Group for Clinical Cancer Research, Bern, Switzerland.
  • Grardel N; Division of Hematology, Department of Oncology, University Hospital and University of Geneva, Geneva, Switzerland.
  • Asnafi V; Hématologie Clinique et Thérapies Cellulaires, Hôpital Haut-Lévêque, Pessac, France.
  • Lhéritier V; University Paris Diderot, Paris, France.
  • Soulier J; Clinical Hematology Department, Saint-Louis Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France.
  • Dombret H; EA-3518, Institut Universitaire d'Hématologie, Paris, France.
  • Clappier E; Service d'Hématologie, HIA Percy, Clamart, France.
Blood ; 133(3): 280-284, 2019 01 17.
Article em En | MEDLINE | ID: mdl-30510083
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia-Linfoma Linfoblástico de Células Precursoras B / Fator de Transcrição PAX5 / Mutação / Recidiva Local de Neoplasia Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Humans Idioma: En Revista: Blood Ano de publicação: 2019 Tipo de documento: Article País de afiliação: França País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia-Linfoma Linfoblástico de Células Precursoras B / Fator de Transcrição PAX5 / Mutação / Recidiva Local de Neoplasia Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Humans Idioma: En Revista: Blood Ano de publicação: 2019 Tipo de documento: Article País de afiliação: França País de publicação: Estados Unidos